×

Sign In

Search
Home

Novavax’s COVID-flu combo and standalone flu shots improve immunity in late-stage study

By Thomson Reuters Jun 11, 2025 | 6:11 AM

(Reuters) -Novavax’s experimental COVID-19-influenza combination and standalone influenza vaccines showed strong immune responses in some patients tested in a late-stage study, the company said on Wednesday.

(Reporting by Mariam Sunny in Bengaluru; Editing by Shilpi Majumdar)

Solar stocks drop after Senate proposal to phase out tax credits by 2028

Exclusive-Ferrari delays second EV model to at least 2028 because of weak demand, sources say

Wall Street futures edge lower as Mideast conflict continues

China's JAC to expand use of Huawei smart car solutions, including assisted driving

A shrinking FEMA puts lake town's rebuilding plans in limbo

US set to object to green jet fuel recommendation at UN aviation council, sources say

Privacy Policy
Terms Of Service

Copyright © 2025. All Rights Reserved.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

For the health and safety of everyone, our offices are temporarily closed to the public. If you have won a prize from us we will be mailing it to you or will contact you with specific information needed to redeem your prize. Feel free to call us with questions during weekday business hours at 715-842-1672.